Joyance Partners invests in early-stage companies that leverage science and technology to cultivate joy and improve the human experience, with a core focus on personal health, techbio, sustainability, and consumer wellness.
About Joyance Partners
Joyance Partners is a Bay Area-based seed fund founded by Howard Morgan and Mike Edelhart, with a distinctive thesis focused on companies that deliver quantifiable joy or positive emotional outcomes, including a meaningful slice of investments in mental health, behavioral health, well-being, longevity, and consumer health technology. The fund writes initial checks of roughly $250K to $1M at seed and pre-seed, typically as a co-investor with small lead capacity in the right deal, and has built a portfolio across hundreds of companies. Healthcare exposure is meaningful and concentrated in well-being, mental health, and longevity rather than acute clinical care or therapeutics. AI focus is welcome where it advances the joy thesis. Founders best suited are seed-stage CEOs in mental health, behavioral health, well-being, or longevity with a consumer or hybrid consumer-clinical model, who want an active and well-networked seed partner. Founders who do not fit include therapeutics, capital-intensive devices, traditional B2B healthcare software, and growth-stage rounds. Geographic preference is global with a US bias. The entry path is warm introduction through a portfolio CEO, a Bay Area or New York-area operator in well-being or mental health, or an angel co-investor. LinkedIn outreach to a partner with a focused well-being thesis articulation and traction summary is a reasonable secondary option given the high portfolio velocity. Expect a fast process and a partner that prizes founder energy and a clear well-being thesis alongside commercial fundamentals.
Founder reviews
Healthcare AI tools backed by Joyance Partners
Tools made by companies in Joyance Partners's portfolio that we cover in the directory.
Portfolio companies in our directory
Other portfolio companies
Companies in Joyance Partners's portfolio not currently in our directory.
- Epicore Biosystems · 2018
- Nervonik
- Lark
Team
Pitch / review this investor
Have you raised from Joyance Partners? Founders only — share your honest experience (anonymous OK, moderated before publishing).



